These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26770925)

  • 1. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.
    Elsabaawy MM; Abdelhamid SR; Alsebaey A; Abdelsamee E; Obada MA; Salman TA; Rewisha E
    Clin Mol Hepatol; 2015 Dec; 21(4):365-71. PubMed ID: 26770925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.
    Sersté T; Francoz C; Durand F; Rautou PE; Melot C; Valla D; Moreau R; Lebrec D
    J Hepatol; 2011 Oct; 55(4):794-9. PubMed ID: 21354230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
    Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
    Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
    Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
    Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.
    Nasr G; Hassan A; Ahmed S; Serwah A
    J Cardiovasc Dis Res; 2010 Jul; 1(3):136-44. PubMed ID: 21187868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
    García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
    Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-paracentesis circulatory derangements are related to monocyte activation.
    Carl DE; Ghosh S; Cheng J; Gehr TW; Stravitz RT; Sanyal A
    Liver Int; 2014 Aug; 34(7):1001-7. PubMed ID: 24373155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
    Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
    Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
    Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
    Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities.
    El-Ashry N; El-Damarawy M; Salem M; Mogawer S
    J Egypt Soc Parasitol; 2007 Aug; 37(2):571-84. PubMed ID: 17985589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
    Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
    J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
    Ginès A; Fernández-Esparrach G; Monescillo A; Vila C; Domènech E; Abecasis R; Angeli P; Ruiz-Del-Arbol L; Planas R; Solà R; Ginès P; Terg R; Inglada L; Vaqué P; Salerno F; Vargas V; Clemente G; Quer JC; Jiménez W; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1002-10. PubMed ID: 8831595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
    Widjaja FF; Khairan P; Kamelia T; Hasan I
    Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.